Stienlauf Shmuel, Yahalom Vered, Schwartz Eli, Shinar Eilat, Segal Gad, Sidi Yechezkel
Sheba Medical Center, Tel Hashomer, Israel.
Emerg Infect Dis. 2009 Jul;15(7):1116-8. doi: 10.3201/eid1507.080796.
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
在以色列献血者中,1型人类嗜T细胞病毒(HTLV-1)的感染率为每10万人中有1例感染。在来自东欧、中东和拉丁美洲的献血者中,感染率分别为7.7/10万、14.6/10万和20.4/10万。在以前已知HTLV-1为地方性流行的地区以外,HTLV-1的感染率可能很高。